Innovation & Technology transfer
Four companies have been created since launch of the program.
Resilience : a mobile application to better manage the disease.
ORAKL : development of functional in vitro diagnostic tests, “organograms”, to predict the responses of cancers to drugs.
Cure51 : learning from cancer survivors
Elikya Therapeutics : innovative molecules for cancer treatment.
IHU PRISM founders
Where to find us
Prism IHU
Bâtiment de médecine moléculaire
32 Rue Camille Desmoulins
94800 Villejuif
Tél. +33(0)1 42 11 00 00
info -at- prism.center
Links
Press
Work with us
Call for project
Guidelines for funding acknowledgement
Accessibility
Cookies Policy
Legal notice